Eylea 40mg/ mL Solution for Intravitreal Injection Philippinen - Englisch - FDA (Food And Drug Administration)

eylea 40mg/ ml solution for intravitreal injection

bayer philippines, inc. - aflibercept - solution for intravitreal injection - 40mg/ ml

Vsiqq 120 mg/mL (27.6 mg/0.23 mL) Solution For Injection (Intravitreal) Philippinen - Englisch - FDA (Food And Drug Administration)

vsiqq 120 mg/ml (27.6 mg/0.23 ml) solution for injection (intravitreal)

n/a; importer: novartis healthcare philippines, inc.; distributor: novartis healthcare philippines, inc. - brolucizumab - solution for injection (intravitreal) - 120 mg/ml (27.6 mg/0.23 ml)

Vabysmo 6 mg/0.05 mL (120 mg/mL) Solution For Intravitreal Injection Philippinen - Englisch - FDA (Food And Drug Administration)

vabysmo 6 mg/0.05 ml (120 mg/ml) solution for intravitreal injection

f. hoffman-la roche ltd.; importer: roche (philippines), inc.; distributor: roche (philippines), inc. - faricimab - solution for intravitreal injection - 6 mg/0.05 ml (120 mg/ml)

EYLEA SOLUTION FOR INJECTION IN PREFILLED SYRINGE 2MG Singapur - Englisch - HSA (Health Sciences Authority)

eylea solution for injection in prefilled syringe 2mg

bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl

EYLEA SOLUTION FOR INJECTION IN VIAL 2MG Singapur - Englisch - HSA (Health Sciences Authority)

eylea solution for injection in vial 2mg

bayer (south east asia) pte ltd - aflibercept - injection, solution - 2.0mg/50mcl - aflibercept 2.0mg/50mcl

VABYSMO SOLUTION FOR INJECTION 6MG0.05ML Singapur - Englisch - HSA (Health Sciences Authority)

vabysmo solution for injection 6mg0.05ml

roche singapore pte. ltd. - faricimab - injection, solution - faricimab 6.00mg/0.05ml

BEOVU  brolucizumab (rbe) 120 mg/mL solution for injection in vial Australien - Englisch - Department of Health (Therapeutic Goods Administration)

beovu brolucizumab (rbe) 120 mg/ml solution for injection in vial

novartis pharmaceuticals australia pty ltd - brolucizumab, quantity: 120 mg/ml - injection, solution - excipient ingredients: sodium citrate; sucrose; polysorbate 80; water for injections - beovu is indicated for the treatment of: - neovascular (wet) age-related macular degeneration (amd). - diabetic macular oedema (dme)

OZURDEX IMPLANT Kanada - Englisch - Health Canada

ozurdex implant

abbvie corporation - dexamethasone - implant - 0.7mg - dexamethasone 0.7mg - corticosteroids

BYOOVIZ SOLUTION Kanada - Englisch - Health Canada

byooviz solution

samsung bioepis co., ltd - ranibizumab - solution - 10mg - ranibizumab 10mg